Role of oxidative stress in pancreatic β-cell dysfunction

Annals of the New York Academy of Sciences

Volumn 1011, Issue , 2004, Pages 168-176

  Kajimoto, Yoshitaka ^a   Kaneto, Hideaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; Glucose toxicity; Insulin gene; JNK; Oxidative stress; PDX 1

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIOXIDANT; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PANCREATIC AND DUODENAL HOMEOBOX FACTOR 1; PROTEIN KINASE C INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INHIBITION KINETICS; INSULIN DEGRADATION; INSULIN RELEASE; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET BETA CELL DYSFUNCTION; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ANIMALIA;

EID: 2342517248     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1293.017     Document Type: Conference Paper

References (58)

1. WEIR, G.C., D.R. LAYBUTT, H. KANETO, et al. 2001. β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 50: S154-S159.
2. TOKUYAMA, Y., J. STURIS, A.M. DEPAOLI, et al. 1995. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44: 1447-1457.
3. ZANGEN, D.H., S. BONNER-WEIR, C.H. LEE, et al. 1997. Reduced insulin, GLUT2, and IDX-1 in β-cells after partial pancreatectomy. Diabetes 46: 258-264.
4. JONAS, J.-C., A. SHARMA, W. HASENKAMP, et al. 1999. Chronic hyperglycemia triggers loss of pancreatic β-cell differentiation in an animal model of diabetes. J. Biol. Chem. 274: 14112-14121.
5. ROBERTSON, R.P., H.-J. ZHANG, K.L. PYZDROWSKI & T.F. WALSETH. 1992. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J. Clin. Invest. 90: 320-325.
6. SHARMA, A., L.K. OLSON, R.P. ROBERTSON & R. STEIN. 1995. The reduction of insulin gene transcription in HIT-T15β chronically exposed to high glucose concentration is associated with loss of RIPE3β1 and STF-1 transcription factor expression. Mol. Endocrinol. 9: 1127-1134.
7. FINKEL, T. & N.J. HOLBROOK. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247.
8. DANDONA, P., K. THUSU, S. COOK, et al. 1996. Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445.
9. LEINONEN, J., T. LEHTIMAKI, S. TOYOKUNI, et al. 1997. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 417: 150-152.
10. BAYNES, J.W. & S.R. THORPE. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
11. NISHIKAWA, T., D. EDELSTEIN, X.L. DU, et al. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
12. BROWNLEE, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
13. KANETO, H., J. FUJII, T. MYINT, et al. 1996. Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem. J. 320: 855-863.
14. MATSUOKA, T., Y. KAJIMOTO, H. WATADA, et al. 1997. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99: 144-150.
15. TIEDGE, M., S. LORTZ, J. DRINKGERN & S. LENZEN. 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46: 1733-1742.
16. IHARA, Y., S. TOYOKUNI, K. UCHIDA, et al. 1999. Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932.
17. KANETO, H., Y. KAJIMOTO, J. MIYAGAWA, et al. 1999. Beneficial effects of antioxidants for diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48: 2398-2406.
18. TANAKA, Y., C.E. GLEASON, P.O.T. TRAN, et al. 1999. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad. Sci. USA 96: 10857-10862.
19. KANETO, H., Y. KAJIMOTO, Y. FUJITANI, et al. 1999. Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in β-cell dysfunction. Diabetologia 42: 1093-1097.
20. KAJIMOTO, Y., T. MATSUOKA, H. KANETO, et al. 1999. Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells. Diabetologia 42: 1417-1424.
21. MAECHLER, P., L. JORNOT & C.B. WOLLHEIM. 1999. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J. Biol. Chem. 274: 27905-27913.
22. IHARA, Y., Y. YAMADA, S. TOYOKUNI, et al. 2000. Antioxidant a-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett. 473: 24-26.
23. KANETO, H., G. XU, K.-H. SONG, et al. 2001. Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function by provoking oxidative stress. J. Biol. Chem. 276: 31099-31104.
24. TANAKA, Y., P.O. TRAN, J. HARMON & R.P. ROBERTSON. 2002. A role of glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc. Natl. Acad. Sci. USA 99: 12363-12368.
25. GOROGAWA, S., Y. KAJIMOTO, Y. UMAYAHARA, et al. 2002. Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57: 1-10.
26. SAKAI, K., K. MATSUMOTO, T. NISHIKAWA, et al. 2003. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochem. Biophys. Res. Commun. 300: 216-222.
27. ROBERTSON, R.P., J. HARMON, P.O. TRAN, et al. 2003. Glucose toxicity in β-cells: type2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52: 581-587.
28. EVANS, J.L., I.D. GOLDFINE, B.A. MADDUX & G.M. GRODSKY. 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8.
29. OHLSSON, H., K. KARLSSON & T. EDLUND. 1993. IPF1, a homeodomain-containing-transactivator of the insulin gene. EMBO J. 12: 4251-4259.
30. LEONARD, J., B. PEERS, T. JOHNSON, et al. 1993. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol. Endocrinol. 7: 1275-1283.
31. MILLER, C.P., R.E. MCGEHEE & J.F. HABENER. 1994. IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J. 13: 1145-1156.
32. JONSSON, J., L. CARLSSON, T. EDLUND & H. EDLUND. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 37: 606-609.
33. AHLGREN, U., J. JONSSON & H. EDLUND. 1996. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122: 1409-1416.
34. OFFIELD, M.F., T.L. JETTON, P. LABOSKY, et al. 1996. PDX-1 is required for pancreas outgrowth and differentiation of the rostral duodenum. Development 122: 983-985.
35. KANETO, H., J. MIYAGAWA, Y. KAJIMOTO, et al. 1997. Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development: a potential role of PDX-1 in the transcriptional activation. J. Biol. Chem. 272: 29137-29143.
36. SHARMA, A., D.H. ZANGEN, P. REITZ, et al. 1999. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48: 507-513.
37. BONNER-WEIR, S., M. TANEJA, G.C. WEIR, et al. 2000. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97: 7999-8004.
38. WATADA, H., Y. KAJIMOTO, J. MIYAGAWA, et al. 1996. PDX-1 induces insulin and glucokinase gene expression in αTC1 clone 6 cells in the presence of betacellulin. Diabetes 45: 1826-1831.
39. SERUP, P., J. JENSEN, F.G. ANDERSEN, et al. 1996. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc. Natl. Acad. Sci. USA 93: 9015-9020.
40. YOSHIDA, S., Y KAJIMOTO, T. YASUDA, et al. 2002. PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. Diabetes 51: 2505-2513.
41. KOJIMA, H., T. NAKAMURA, Y. FUJITA, et al. 2002. Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 51: 1398-1408.
42. AHLGREN, U., J. JONSSON, L. JONSSON, et al. 1998. β-Cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev. 12: 1763-1768.
43. WANG, H., P. MAECHLER, B. RITZ-LASER, et al. 2001. Pdx 1 level defines pancreatic gene expression pattern and cell lineage differentiation. J. Biol. Chem. 276: 25279-25286.
44. WAEBER, G., N. THOMPSON, P. NICOD & C. BONNY. 1996. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/EDX-1 homeobox factor. Mol. Endocrinol. 10: 1327-1334.
45. WATADA, H., Y. KAJIMOTO, Y. UMAYAHARA, et al. 1996. The human glucotinase gene β-cell-type promoter: an essential role of insulin promoter factor 1 (IPF1)/PDX-1 in its activation in HIT-T15 cells. Diabetes 45: 1478-1488.
46. DUTTA, S., S. BONNER-WEIR, M. MONTMINY & C. WRIGHT. 1998. Regulatory factor linked to late-onset diabetes? Nature 392: 560.
47. STOFFERS, D.A., N.T. ZINKIN, V. STANOJEVIC, et al. 1997. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15: 106-110.
48. STOFFERS, D.A., J. FERRER, W.L. CLARKE & J.F. HABENER. 1997. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17: 138-139.
49. KAJIMOTO, Y., H. WATADA, T. MATSUOKA, et al. 1997. Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells. J. Clin. Invest. 100: 1840-1846.
50. 2terminal kinase. Diabetes 52: 2896-2904.
51. KANETO, H., G. XU, N. FUJII, et al. 2002. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem. 277: 30010-30018.
52. CORBETT, J.A., J.L. WANG, M.A. SWEETLAND, et al. 1992. Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans: evidence for the β-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90: 2384-2391.
53. ANKARCRONA, M., J.M. DYPBUKT, B. BRUNE & P. NICOTERA. 1994. Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213: 172-177.
54. KANETO, H., J. FUJII, H.G. SEO, et al. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738.
55. AMMENDRUP, A., A. MAILLARD, K. NIELSEN, et al. 2000. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes 49: 1468-1476.
56. BONNY, C., A. OBERSON, M. STEINMANN, et al. 2000. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J. Biol. Chem. 275: 16466-16472.
57. MANDRUP-POULSEN, T. 2001. β-Cell apoptosis: stimuli and signaling. Diabetes 50: S58-S63.
58. BONNY, C., A. OBERSON, S. NEGRi, et al. 2001. Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes 50: 77-82.